Table 1 from A Phase 1 Safety Study of Evexomostat (SDX-7320) in Patients with Late-Stage Cancer: An Antiangiogenic, Insulin-Sensitizing Drug Conjugate Targeting METAP2
收藏Figshare2025-06-23 更新2026-04-28 收录
下载链接：
https://figshare.com/articles/dataset/Table_1_from_A_Phase_1_Safety_Study_of_Evexomostat_SDX-7320_in_Patients_with_Late-Stage_Cancer_An_Antiangiogenic_Insulin-Sensitizing_Drug_Conjugate_Targeting_METAP2/29381350
下载链接
链接失效反馈官方服务：
资源简介：
Patient demographics and baseline clinical characteristics
创建时间：
2025-06-23
